Schedule 13G ownership disclosure

PDL BIOPHARMA INC

Security class unavailable · CUSIP: 69329Y104

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,811,080
Percent of class
5.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-002640
Form type
SC 13G
Filer
BRANDES INVESTMENT PARTNERS, LP
CIK
CIK 1015079
Filed
Jan 09, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub